CEO SUMMARY: Medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Although labs have received PAMA reprieves from Congress over the last few years, laboratory associations argue that Congress needs to vote on long-term reforms rather than stop-gap measures. With President Donald Trump’s administration cementing its power […]
Lab Stakeholders Discuss PAMA Reform
Washington insiders contend that 2025 may be a pivotal year for clinical laboratories to speak up
- By Stephen Beale
- > From the Volume XXXII, No. 10 - July 14, 2025 Issue
- Tags: acla, Administration for a Healthy American, AdvaMed, AdvaMedDx, American Clinical Laboratory Association, CBO, Centers for Medicare and Medicaid Services, clfs, Clinical Laboratory Fee Schedule, CMS, Congress, Congressional Budget Office, consumer price index, CRD Associates, Donald Trump, Erin Morton, European Union, executive war college, final rule, Food and Drug Administration, HHS, in vitro diagnostics, IVD, ivd/lab informatics, laboratory-developed test, ldt, MAHA, Make America Healthy Again, Medicare Part B, national independent laboratory association, NILA, One Big Beautiful Bill, PAMA, pandemic, Protecting Access to Medicare Act, SALSA, Saving Access to Laboratory Services Act, Stop Lab Cuts, Susan Van Meter, tariffs, US Department of Health and Human Services, White House, Zack Rothstein
